alpha-N-acetylglucosaminidase stimulator (SanOrphan)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha-N-acetylglucosaminidase stimulator (SanOrphan)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-N-acetylglucosaminidase stimulants
TargetsAlpha-N-acetylglucosaminidase
Therapy Area/IndicationsMucopolysaccharidosis III
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDorphan SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDorphan SA
Active IndicationsN/A
Inactive IndicationsMucopolysaccharidosis III

Other Information

ATC CodeN/A
Related LinksN/A